Any Questions? A Sober Look at MDMA.
Biol Psychiatry August 1, 2021 Luke G. Petry, Monica Sharma, Aaron S. Wolfgang et al. 4 citations
The text critically examines the use of MDMA in therapeutic contexts, arguing that the current enthusiasm for MDMA-assisted therapy may overlook significant risks and methodological shortcomings. It questions the robustness of evidence supporting its efficacy for conditions like PTSD, highlighting issues such as small sample sizes, lack of long-term safety data, and potential for adverse effects. The author suggests that a sober, evidence-based evaluation is necessary before embracing MDMA as a treatment, emphasizing the need for rigorous research and caution against premature adoption.